Cochrane Abstracts
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
There's more to see -- the rest of this topic is available only to subscribers.
Citation
"Tafenoquine for Preventing Relapse in People With Plasmodium Vivax Malaria." Cochrane Abstracts, John Wiley & Sons, Inc, 2025. Evidence Central, evidence.unboundmedicine.com/evidence/view/Cochrane/436587/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. Cochrane Abstracts. John Wiley & Sons, Inc; 2025. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436587/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria. Accessed January 25, 2025.
Tafenoquine for preventing relapse in people with Plasmodium vivax malaria. (2025). In Cochrane Abstracts. John Wiley & Sons, Inc. https://evidence.unboundmedicine.com/evidence/view/Cochrane/436587/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria
Tafenoquine for Preventing Relapse in People With Plasmodium Vivax Malaria [Internet]. In: Cochrane Abstracts. John Wiley & Sons, Inc; 2025. [cited 2025 January 25]. Available from: https://evidence.unboundmedicine.com/evidence/view/Cochrane/436587/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria.
* Article titles in AMA citation format should be in sentence-case
TY - ELEC
T1 - Tafenoquine for preventing relapse in people with Plasmodium vivax malaria
ID - 436587
BT - Cochrane Abstracts
UR - https://evidence.unboundmedicine.com/evidence/view/Cochrane/436587/all/Tafenoquine_for_preventing_relapse_in_people_with_Plasmodium_vivax_malaria
PB - John Wiley & Sons, Inc
DB - Evidence Central
DP - Unbound Medicine
ER -
